GeneDx Holdings Corp - Ordinary Shares - Class A

-0.06 (-1.64%)
4:10:13 PM EDT: $3.56 -0.03 (-0.84%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)91.01M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$52.42 Million
Adjusted EPS-$1.30
See more estimates
10-Day MA$4.07
50-Day MA$5.57
200-Day MA$9.02
See more pivots

GeneDx Holdings Corp - Ordinary Shares - Class A Stock, NASDAQ:WGS

North Tower, 333 Ludlow Street, Stamford, Connecticut 06902-6987
United States of America
Phone: +1.800.298.6470
Number of Employees: 1100


GeneDx Holdings Corp. is a patient centered health intelligence company. It engages in transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. The firm, through its Centrellis health intelligence platform, generates a more complete understanding of disease and wellness and provides science-driven solutions to the most pressing medical needs. The company was founded by Eric Schadt in October 2015 and is headquartered in Stamford, CT.